VICARIOUS SRGCL INC A by Vicarious Surgical Inc. (RBOT) Stock Price Target 2026

The average analyst price target for VICARIOUS SRGCL INC A by Vicarious Surgical Inc. is $9.67, 644566.7% above the current price. Of 3 analysts, 3 rate it Hold. Targets range from $7 to $12. The latest change came on Aug 13, 2025, when Piper Sandler lowered its price target on VICARIOUS SRGCL INC A by Vicarious Surgical Inc. from $8.50 to $7 and kept a Neutral rating.

The Average Analyst Price Target for VICARIOUS SRGCL INC A by Vicarious Surgical Inc. is $9.67.

Price Target Range — 6 Quarters

Analyst Consensus — 3 Analysts

3Hold

Consensus RatingHold# Analysts3Avg. Consensus PT$9.67Upside to Avg. PT+644566.7%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for VICARIOUS SRGCL INC A by Vicarious Surgical Inc. Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Dec 12, 2025	BTIG	Ryan Zimmerman	Suspends	Neutral	—
Aug 13, 2025	Piper Sandler	Adam Maeder	PT Cut	Neutral	$9→$7
Mar 18, 2025	Piper Sandler	Adam Maeder	PT Cut	Neutral	$11→$9
Nov 13, 2024	Piper Sandler	Adam Maeder	PT Cut	Neutral	$12→$11
Aug 13, 2024	Piper Sandler	Adam Maeder	Maintained	Neutral	$30→$12
Jul 15, 2024	Morgan Stanley	Patrick Wood	PT Cut	Equal-Weight	$18→$10
Mar 5, 2024	Piper Sandler	Adam Maeder	PT Cut	Neutral	$45→$30
Dec 4, 2023	Morgan Stanley	Patrick Wood	Initiate	Equal-Weight	$18
Nov 14, 2023	BTIG	Ryan Zimmerman	Downgrade	Buy→Neutral	—
Nov 14, 2023	Canaccord Genuity	Caitlin Cronin	Downgrade	Buy→Hold	$270→$12

Analyst Ratings News

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $7

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $8.5 to $7.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $8.5

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $10.5 to $8.5.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $10.5

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $12 to $10.5.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Adjusts Price Target To $12 from $30 (1-for-30 Reverse Stock Split)

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral, adjusts target to $12 from $30 (1-30 Reverse Stock Split)

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Vicarious Surgical, Lowers Price Target to $10

Morgan Stanley analyst Patrick Wood maintains Vicarious Surgical (NYSE:RBOT) with a Equal-Weight and lowers the price target from $18 to $10.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $1

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $1.5 to $1.

Benzinga Newsdesk